Gene therapy aims to fix genetic problems at their source by manipulating cellular DNA
In short: Gene therapy is a medical technology that treats disease by adding, replacing, or editing genetic material within living cells. While early trials faced significant setbacks, modern approaches now use sophisticated viral and non-viral delivery systems to address conditions ranging from inherited disorders to cancer, fundamentally changing how we approach medicine.
The concept of gene therapy emerged in the 1960s, evolving from early experiments that injected DNA into mammalian cells. By 1980, Martin Cline performed the first human attempt at modifying DNA, though it was not until 1990 that French Anderson initiated the first therapeutic trial. The field has since expanded significantly, with over 2,900 clinical trials conducted between 1989 and 2018. Regulatory milestones include the 2003 approval of Gendicine in China and the 2012 approval of alipogene tiparvovec in the West.
At its core, gene therapy uses a vector to deliver therapeutic genetic material into cells. Viral vectors, such as adeno-associated viruses (AAVs) and lentiviruses, are commonly used because they naturally excel at entering cells. Alternatively, non-viral methods—including naked DNA, lipoplexes, and nanoparticles—are gaining traction for their potential in large-scale production and reduced immune responses. Once inside, the genetic material may simply act as a temporary blueprint or integrate into the host's genome to provide long-term expression.
The field is divided into somatic cell gene therapy (SCGT), which affects only the patient, and germline gene therapy (GGT), which creates heritable changes. While SCGT is the focus of mainstream clinical research, GGT remains prohibited in many countries due to ethical concerns and risks to future generations. Recent advancements, particularly CRISPR-based gene editing, have shifted the focus from merely replacing defective genes to precisely correcting them, offering new hope for treating complex conditions like sickle cell disease and various cancers.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Gene therapy
- Also: Science — The Basic Science of Gene Therapy · CC0 (metadata)
- Also: Science — Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease · CC0 (metadata)
To cite this card, link to https://intellectplus.co.uk/app/technology-gene-therapy.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Health · Latest · A–Z · All topics